Pharmaceutical & Healthcare
Tim has worked with leading pharmaceutical and healthcare companies around the world, providing asset valuations to support insurance, financial reporting, and purchase price allocation.
His expertise spans large-scale manufacturing facilities, global pharmaceutical brands, and specialist medical producers, helping clients navigate the highly regulated and technically complex healthcare landscape with accuracy and confidence.
Managing Director
Tim Howard ASA (MT&S) MRICS
RECENT
PROJECTS
Purchase Price Allocation
- Valuation of a multinational pharmaceutical company in Waterford, Ireland
- Valuation of multiple pharmaceutical manufacturing facilities across the USA
- Valuation of a major international pharmaceutical company for acquisition-related reporting (2019–2020)
Insurance Valuation
- Long-term valuation of Alcon, a global eye care leader, for insurance purposes (2019–2025)
- Insurance valuation of a major international pharmaceutical company, ensuring comprehensive asset protection and risk assessment